Alphabet Inc’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.1M Hold
2,812,500
0.2% 18
2025
Q4
$11.4M Hold
2,812,500
0.44% 16
2025
Q3
$9.98M Hold
2,812,500
0.41% 16
2025
Q2
$7.68M Hold
2,812,500
0.36% 15
2025
Q1
$4.72M Hold
2,812,500
0.3% 20
2024
Q4
$4.58M Hold
2,812,500
0.27% 17
2024
Q3
$11.7M Hold
2,812,500
0.64% 13
2024
Q2
$15.4M Hold
2,812,500
0.78% 13
2024
Q1
$28.1M Hold
2,812,500
1.12% 12
2023
Q4
$11.5M Hold
2,812,500
0.53% 16
2023
Q3
$10.9M Hold
2,812,500
0.7% 15
2023
Q2
$16.8M Hold
2,812,500
0.9% 17
2023
Q1
$9.2M Hold
2,812,500
0.51% 24
2022
Q4
$11.1M Hold
2,812,500
0.65% 22
2022
Q3
$16.9M Hold
2,812,500
0.86% 20
2022
Q2
$18.1M Hold
2,812,500
0.98% 18
2022
Q1
$23.2M Hold
2,812,500
0.75% 20
2021
Q4
$43.5M Hold
2,812,500
1.05% 18
2021
Q3
$63.3M Hold
2,812,500
1.5% 13
2021
Q2
$55.3M Hold
2,812,500
1.13% 13
2021
Q1
$94.1M Buy
+2,812,500
New +$91.6M 3.8% 8

Other funds holding SANA

Alphabet Inc's SANA Position: Q1 2026 in Review

Alphabet Inc held its Sana Biotechnology (SANA) position steady in Q1 2026 at 2,812,500 shares worth $8.1M. The position accounts for 0.2% of the portfolio, ranked #18.

Alphabet Inc first reported a position in SANA in Q1 2021 and has held it in 21 quarters since. The position peaked at $94.1M in Q1 2021. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Alphabet Inc held 2,812,500 shares of Sana Biotechnology worth $8.1M as of Q1 2026.
  • Alphabet Inc left its Sana Biotechnology share count unchanged in Q1 2026.
  • Sana Biotechnology made up 0.2% of Alphabet Inc's portfolio in Q1 2026, its #18 holding.
  • Alphabet Inc first reported a position in Sana Biotechnology in Q1 2021 and has held it in 21 quarters since.
  • Alphabet Inc's Sana Biotechnology position peaked at $94.1M in Q1 2021.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Alphabet Inc's 13F filing for Q1 2026, filed 8 May 2026.